A team including researchers from Israel’s Technion has developed an innovative technique that they believe will cure deformities and blindness caused by ectodermal dysplasia, which affects seven out of every 10,000 babies born in the world. Via in-vitro experiments, damaged cells caused by mutant p63 genes can be greatly improved using a chemical substance called PRIMA-APR246.
http://www.jpost.com/Health/Article.aspx?id=302834